Author

K. Chau

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:metagenomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Ashworth· 1 shared A. K. Debnath· 1 shared A. Roohi· 1 shared A. S. Walker· 1 shared A. Scott· 1 shared C. D. Hillyer· 1 shared C. Ellison· 1 shared C.-J. Ku· 1 shared

Activity by Year

2018-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Ashworth

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A workflow for the detection of antibiotic residues, measurement of water chemistry and preservation of hospital sink drain samples for metagenomic sequencing

G. Rodger, K. Chau, P. Aranega-Bou, A. Roohi, G. Moore, K. L. Hopkins, S. Hopkins, A. S. Walker, N. Stoesser

The paper validates a workflow for detecting antibiotic residues and measuring water chemistry in hospital sink samples, and confirms boric acid preserves microbial and resistome composition for metagenomic sequencing.

bioRxiv · Sep 22, 2023Microbiology

Discovery of highly potent small molecule pan-coronavirus fusion inhibitors

F. Curreli, K. Chau, T.-T. Tran, I. Nicolau, S. Ahmed, P. Das, C. D. Hillyer, M. Premenko-Lanier, A. K. Debnath

This paper discovers and characterizes NBCoV63, a potent small molecule inhibitor effective against multiple SARS-CoV-2 variants and other coronaviruses.

bioRxiv · Jan 17, 2023Pharmacology & Toxicology

Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA

F. Collin, Y. Ning, T. Phillips, E. McCarthy, A. Scott, C. Ellison, C.-J. Ku, G. D. Guler, K. Chau, A. Ashworth, S. R. Quake, S. Levy

This study identifies 5-hydroxymethylcytosine (5hmC) signatures in circulating cell-free DNA to detect early-stage pancreatic cancer with high accuracy.

bioRxiv · Sep 26, 2018Cancer Biology